4013

COM:HMG

Dr. Sulaiman Al Habib Medical Group

  • Stock

Last Close

271.20

21/11 12:16

Market Cap

97.93B

Beta: -

Volume Today

161.35K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
337.89M
-
393.40M
16.43%
448.64M
14.04%
529.98M
18.13%
average payables
642.07M
-
716.65M
11.62%
883.23M
23.24%
1.12B
26.91%
average receivables
440.82M
-
815.17M
84.92%
book value per share
12.55
-
14.03
11.79%
15.25
8.70%
16.80
10.10%
18.53
10.32%
capex per share
-2.09
-
-2.16
3.38%
-3.58
65.44%
-4.32
20.73%
-9.99
131.07%
capex to depreciation
-2.86
-
-2.38
16.75%
-3.98
67.03%
-4.89
22.90%
-11.18
128.51%
capex to operating cash flow
-0.69
-
-0.35
49.73%
-0.57
65.08%
-0.53
7.33%
-1.10
105.79%
capex to revenue
-0.15
-
-0.13
11.53%
-0.17
33.75%
-0.18
5.33%
-0.37
101.96%
cash per share
3.42
-
6.68
95.48%
7.55
13.02%
7.85
3.90%
7.49
4.61%
days of inventory on hand
30.92
-
34.69
12.20%
30.18
12.99%
32.18
6.60%
33.04
2.68%
days payables outstanding
68.55
-
57.36
16.32%
59.73
4.13%
63.08
5.61%
74.28
17.76%
days sales outstanding
38.72
-
28.74
25.78%
debt to assets
0.28
-
0.28
0.46%
0.28
1.68%
0.28
0.80%
0.31
11.93%
debt to equity
0.53
-
0.54
0.63%
0.57
6.82%
0.60
4.71%
0.76
27.37%
dividend yield
0.05
-
0.01
70.68%
0.02
21.56%
0.01
11.77%
0.01
2.19%
earnings yield
0.05
-
0.03
38.80%
0.02
11.92%
0.02
12.11%
0.02
3.90%
enterprise value
20.39B
-
38.44B
88.51%
56.90B
48.02%
77.84B
36.81%
101.96B
30.98%
enterprise value over ebitda
17.18
-
25.73
49.78%
30.69
19.29%
38.51
25.49%
42.10
9.30%
ev to operating cash flow
19.25
-
17.65
8.33%
26.07
47.69%
27.37
5.01%
31.93
16.65%
ev to sales
4.07
-
6.56
61.33%
7.85
19.67%
9.37
19.35%
10.72
14.48%
free cash flow per share
0.93
-
4.06
335.41%
2.66
34.57%
3.80
43.16%
-0.87
122.85%
free cash flow yield
0.02
-
0.04
119.70%
0.02
55.81%
0.02
4.93%
-0.00
117.71%
graham net net
-7.23
-
-5.32
26.40%
-7.01
31.64%
-8.07
15.17%
-15.74
95.06%
graham number
26.50
-
30.86
16.44%
36.74
19.07%
42.22
14.90%
49.37
16.93%
income quality
1.17
-
1.93
64.71%
1.45
24.72%
1.58
8.86%
1.56
1.40%
intangibles to total assets
0
-
0
0
0
0
interest coverage
31.03
-
22.99
25.92%
38.69
68.29%
-84.28
317.84%
25.14
129.83%
interest debt per share
6.76
-
7.65
13.21%
8.84
15.43%
10.00
13.23%
14.38
43.72%
inventory turnover
11.81
-
10.52
10.87%
12.09
14.93%
11.34
6.20%
11.05
2.61%
invested capital
0.53
-
0.54
0.63%
0.57
6.82%
0.60
4.71%
0.76
27.37%
market cap
19.25B
-
38.15B
98.18%
56.49B
48.07%
77.07B
36.43%
99.40B
28.97%
net current asset value
-591.52M
-
-543.00M
8.20%
-1.17B
114.89%
-2.32B
98.65%
-4.84B
108.78%
net debt to ebitda
0.96
-
0.19
79.73%
0.22
13.61%
0.38
73.02%
1.06
176.17%
net income per share
2.49
-
3.02
21.29%
3.93
30.43%
4.72
19.91%
5.85
23.94%
operating cash flow per share
3.03
-
6.22
105.65%
6.24
0.22%
8.12
30.28%
9.12
12.28%
payables turnover
5.32
-
6.36
19.51%
6.11
3.96%
5.79
5.31%
4.91
15.08%
receivables turnover
9.43
-
12.70
34.73%
research and ddevelopement to revenue
return on tangible assets
0.10
-
0.11
8.32%
0.13
14.21%
0.13
3.17%
0.13
1.27%
revenue per share
14.33
-
16.75
16.85%
20.72
23.69%
23.74
14.62%
27.17
14.41%
roe
0.20
-
0.21
8.50%
0.26
19.98%
0.28
8.91%
0.32
12.35%
roic
0.11
-
0.13
14.74%
0.16
19.11%
0.16
5.42%
0.18
6.43%
sales general and administrative to revenue
0.02
-
0.02
18.05%
0.01
27.62%
0.02
13.21%
0.02
2.47%
shareholders equity per share
12.55
-
14.03
11.79%
15.25
8.70%
16.80
10.10%
18.53
10.32%
stock based compensation to revenue
tangible asset value
4.59B
-
5.09B
10.84%
5.53B
8.62%
6.11B
10.47%
6.82B
11.71%
tangible book value per share
13.12
-
14.54
10.84%
15.79
8.62%
17.44
10.47%
19.49
11.71%
working capital
1.79B
-
2.16B
20.46%
2.09B
3.26%
1.57B
24.72%
838.68M
46.59%

All numbers in (except ratios and percentages)